A new antifungal molecule, devised by tweaking the structure of prominent antifungal drug Amphotericin B, has the potential to harness the drug’s power against fungal infections while doing away with its toxicity, report researchers at the University of Illinois Urbana-Champaign and collaborators at the University of Wisconsin-Madison. They reported their findings in the journal Nature.